US 8106087
Spiro-oxindole compounds and their uses as therapeutic agents
granted A61PA61P1/04A61P11/00
Quick answer
US patent 8106087 (Spiro-oxindole compounds and their uses as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P13/10, A61P17/02